To the full analysis
Angel Yeast Stock: Growth
600298.SSAngel Yeast reported $2.51B in revenue for fiscal 2025, up 10.1% on the prior year, up 13.4% a year on average over up to five years. That makes 19 years of growth in a row.
Daily figure as of 20 Nov 2026
Revenue (Annual rate)
16.8%
per year from 2006 to 2025, per share 15.4%
Earnings (Annual rate)
16.9%
per year from 2006 to 2025, per share 15.5%
Free cash flow (Annual rate)
24.4%
per year from 2006 to 2025, per share 22.9%
Growth per Year by Period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 13.4% | 14.8% | 16.8% |
| Revenue per share | 12.5% | 14.3% | 15.4% |
| Earnings | 2.4% | 18.6% | 16.9% |
| Earnings per share | 1.6% | 18.1% | 15.5% |
| Free cash flow | −6.5% | 10.2% | 24.4% |
| Free cash flow per share | −7.2% | 9.8% | 22.9% |
Growth Over Time
Since 2015 earnings grew faster than revenue, 18.6% against 14.8% a year, because the net margin rose from 6.6% to 9.2%. Angel Yeast has made a profit in every fiscal year since 2006.
Fiscal Years at a Glance
How Revenue and Earnings Grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $130.75M | $11.86M | $1.83M |
| 2007 | $159.12M | $13.6M | −$29.94M |
| 2008 | $196.69M | $15.67M | −$29.47M |
| 2009 | $252.95M | $31.53M | −$2.75M |
| 2010 | $315.15M | $42.75M | $3.92M |
| 2011 | $373.49M | $44.76M | −$54.12M |
| 2012 | $407.05M | $36.48M | −$145.26M |
| 2013 | $467.91M | $21.97M | −$30.94M |
| 2014 | $548.12M | $22.08M | $42.61M |
| 2015 | $632M | $42.01M | $44.12M |
| 2016 | $729.08M | $80.26M | −$2.56M |
| 2017 | $866.36M | $127.08M | $29.27M |
| 2018 | $1B | $128.5M | $19.71M |
| 2019 | $1.15B | $135.23M | $70.35M |
| 2020 | $1.34B | $205.73M | $162.9M |
| 2021 | $1.6B | $196.28M | −$100.55M |
| 2022 | $1.93B | $198.18M | −$220.06M |
| 2023 | $2.04B | $190.91M | −$57.9M |
| 2024 | $2.28B | $198.69M | −$10.07M |
| 2025 | $2.51B | $231.66M | $116.62M |
Data and Required Disclosures
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026; valuation signal Fairly valued since 7 Nov 2026
- Price: closing price of 20 Nov 2026
- Amounts in US dollars at the ECB reference rate of 19 Nov 2026 ($1 = CN¥6.6667)
- Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2025. MEQIRI calculates the score and fair value itself every night.
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
